Decisions by pharmaceutical companies to seek to develop new therapeutic approaches to any disease are a strategic matter for them alone. No external body advises companies not to carry out research.
The pharmaceutical industry and the Medical Research Council took the lead earlier this year to meet and discuss how therapeutic advances made by the industry in other related fields, such as Alzheimer's disease, could be adopted.
Dr Jeff Kipling
Director of Science and Technology
The Association of the British Pharmaceutical Industry
London SW1Reuse content